A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Several experts stated the demand for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.
Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.
Service Response and Content Elimination
According to TikTok, the platform has taken down problematic material and banned related hashtags and search suggestions. The company stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, populated with photos of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of joining one community, a vendor posted contact information, where most purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages show dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious medical dangers”.
